Notice ID: 4b03726b44b84aef9252555ce4e994a3Award NoticeAwardedArchived
Award Notice Hamilton STAR Vantage 2.0
Awarded on July 23, 2026. Full description on SAM.gov.
Awarded tounder HT942726PE026 (source: SAM.gov award notice)• $349.0K
Overview
- Posted
- July 29, 2026
- Notice type
- Award Notice
- Set-aside
- No Set aside used
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Place of performance
- Dover AFB, Delaware
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
- Award date
- Jul 23, 2026
- Award amount (SAM.gov award notice)
- $349.0K
Identifiers
- Solicitation number
- JA26-06-12
- Notice ID
- 4b03726b44b84aef9252555ce4e994a3
- Award number (PIID)
- HT942726PE026
Description
This was a sole source in accordance with 10 United States Code (U.S.C.) 3204(a)(1) as implemented in FAR 6.103-1(b), One responsible source.
Award Overview
Award Number
HT942726PE026
Award Amount (SAM.gov award notice)
$349.0K
Award Date
Jul 23, 2026
Awardee
Awardee UEI
LD1MPMMCBWJ9
Awardee CAGE Code
22582
Original Solicitation
Notice ID: 4b03726b44b84aef9252555ce4e994a3
Posted Date: Jul 29, 2026
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $5.8MSigned Jul 13, 2026
- $2.7MSigned Feb 19, 2026
- $1.6MSigned Sep 30, 2025
- $301.7KSigned Sep 24, 2025
- $116.0KSigned Sep 15, 2025
Contacts
Contracting Officer
Primary Contact
Kasey Carroll
Secondary Contact
Courtney Piar
Documents
Files (1)
- Download
Redacted Justification and Approval (JA)_Hamilton.pdf
190 KBAdded in Award Notice version 3Posted
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
Award Notice Hamilton STAR Vantage 2.0
Other notices for this solicitation
- Pre-SolicitationRelated noticeJun 12, 2026
Notice of Intent to Sole Source-Hamilton Company
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Answers to Questions attached. Questions are due by 11:00 AM Monday, 16 November 2026. The proposal due date has not been extended. | - | Solicitation | 11/23/2026 |
CN Bio Innovations Limited received a sole source, firm fixed price award for consumables/components compatible with the existing PhysioMimix systems currently in place at USAMRIID. CN Bio Innovations Limited was the only vendor capable of providing consumables/components compatible with the existing CN Bio PhysioMimix systems in use at USAMRIID. | - | Awarded | Open |
The Defense Health Agency Contracting Activity (DHACA) intends to award a Firm Fixed Price, sole source Contract on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to DNA Script Inc, located in Cambridge, MA, under the authority of 41 U.S.C. 1901, as prescribed in RFO FAR 12.102(b) Restricting Competition for acquisitions valued over the SAT. This requirement is for the acquisition of 1 benchtop DNA synthesizer system with a preventative maintenance support contract for an additional 4 years. The benchtop unit shall meet the following minimum essential characteristics: 1. The synthesizer table-top dimensions must not exceed: 48’’ x 26’’ x 29’’. The required vacuum cabinet (freestanding) is 33’’ x 26’’ x 26’’ (inches). 2. The synthesizer shall have same-day throughput e.g. 96 oligos of 20 nucleotides in length in approximately 6 hours and 120 nucleotides in less than 24 hours 3. The synthesizer shall synthesize oligos labeled with fluorophores, quenchers, or biotin with the use of appropriate reagent kits with up to 5 colors in parallel. 4. The synthesizer shall be fully automated: oligos are synthesized, quantified, and normalized in a single synthesis run without user interaction following an approximate range of 15 to 30 minutes of setup. 5. The synthesizer shall have console software that can be installed and hosted on a stand-alone, off-network computer connected to the synthesizer. 6. The synthesizer shall have no harsh organic solvents: the product uses biochemistry, composed of water-based reagents, proprietary enzymes, and proprietary nucleotides that are typically compliant with standard laboratory waste management systems. 7. The synthesizer can perform without any specific environmental control (no need for Argon or any Gas). 8. The synthesizer should have an output power capacity of 1800 W / 2200 VA, 120 VAC input/output voltage and NEMA 5-20P input connection. 9. The synthesizer should produce oligos as they occur in biology, producing oligos that are free of molecular defects or blemishes. 10. The data management software shall provide user authentication features to include: password complexity requirements; automatic logout; limited login attempts; and account inactivity period. 11. The data management software shall have full traceability for synthesis runs, quality control runs, instrument maintenance, reagent usage, user identification, and 5 years of support. 12. The synthesizer shall permit data export to a backup medium. 13. The contractor shall provide method validation services and on-site and off-site operator training, as well as on-site start up support. 14. The contractor shall provide onsite preventative and corrective maintenance for analyzers previously used in biocontainment laboratories (following decontamination). 15. The contractor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor, or authorized reseller for the quoted equipment such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty, and services associated with the equipment shall be in accordance with OEM terms and conditions. DNA Script is the only vendor who has a benchtop DNA synthesizer capable of producing 96 oligonucleotides of 20 nucleotides in lengths in 6 hours and 120 nucleotides in length in 24 hours. DNA Script also has the capability of adding biotin, quenchers, and fluorescent molecules to the oligonucleotides for downstream applications, reducing the cost of targeting pathogens. DNA Script’s synthesizer is the only unit capable of meeting all the government’s minimum essential characteristics. The safety features built into the synthesizer protect users by reducing the use of hazardous chemicals, dedicated fume vents, and gas cylinders limiting exposer to stored chemicals. This announcement fulfills the synopsis requirement under RFO FAR 5.101(a). This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to meet the governments requirement. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Any other firms desiring consideration must submit capability statements and identify their interest and capability in providing these services. Responses to this notice must be received no later than 0900 Eastern Time, 2 November 2026. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email addresses ryan.r.jorgensen.civ@health.mil and jayme.l.fletcher2.civ@health.mil. No phone calls will be accepted. | - | Special Notice | 11/02/2026 |
This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, “Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 effective date 3/13/2026. This solicitation is unrestricted. The associated North American Industrial Classification System (NAICS) code for this procurement is 334516, with a small business size standard of 1000 employees. The FSC/PSC is 6515. VA New Jersey Health Care System’s Research and Development Service located at 385 Tremont Avenue East Orange, NJ 07018-1023 is seeking to purchase SomnoFlo Electronic Vaporizer Systems Brand Name or Equal. Please see attached solicitation for additional details. | - | Combined Synopsis | 09/18/2026 |
INTENT TO SOLE SOURCE AND JUSTIFICATION | - | Special Notice | 08/25/2026 |
Additional Details
Solicitation Number
JA26-06-12
Archive Date
Aug 7, 2026
Office Address
FORT DETRICK, MD, 21702